Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma

NCT02030483 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped The company providing one of the study drugs withdrew its support due to low enrollment. Therefore, we had to close the study due to lack of funding.

Conditions

Multiple Myeloma

Interventions

DRUG: Palbociclib
DRUG: Dexamethasone
DRUG: Lenalidomide

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]